Search Results for "overcoming challenges"

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Apr 8^th • 4 mins read

Ioannis Tsagakis and Maria Papatriantafyllou

Safeguarding cancer research funding by European charities amidst the COVID-19 pandemic

Nov 22^nd • 3 mins read

Siddharth Agrawal, Nidhi Bansal

Advances and Challenges in Pediatric and Childhood Cancers

Jun 27^th • 2 mins read

Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

Aug 16^th • 8 mins read

Dean Bottino, Rachael Liu, Hojjat Bazzazi, Karthik Venkatakrishnan

Quantitative Translation in Immuno-Oncology Research and Development

Jul 9^th • 3 mins read

Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Jun 18^th • 30 mins read

Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr

The Oncology Data Network (ODN): Methodology, Challenges, and Achievements

May 21^st • 8 mins read

Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD

Outcome measures for oncology alternative payment models: practical considerations and recommendations

Dec 1^st • 10 mins read

S.E. Abdullah, E. Oflazoglu, J.C. Soria, M.M. Dar

New Realities of Phase I Clinical Trials in the Era of

Oct 7^th • 5 mins read

Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2

Sep 20^th • 12 mins read

M. Ochoa de Olza, M. Oliva, C. Hierro I. Matos, J. Martin-Liberal, E. Garralda

Early-drug development in the era of immuno-oncology: are we ready to face the challenges?

Jun 26^th • 26 mins read

Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Aug 2^nd • 3 mins read

Min Jeong Kim, Hyo Jung Kim, Danbee Kang, Hee Kyung Ahn, Soo-Yong Shin, Juhee Cho, Yeon Hee Park,

Preliminary Attainability Assessment of Real-World Data for Answering Major Clinical Research Questions in Breast Cancer Brain Metastasis: Framework Development and Validation Study

Oct 9^th • 4 mins read

Gracy Crane, John C. W. Lim, Churn-Shiouh Gau, Jipan Xie & Laura Chu

The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations

Jun 28^th • 13 mins read

Kirill Peskov, Ivan Azarov, Lulu Chu, Veronika Voronova, Yuri Kosinsky, Gabriel Helmlinger

Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology

Apr 30^th • 12 mins read

Carrie Printz

Cancer experts point to new advances in research and treatment: A recent report by the American Association for Cancer Research highlights unprecedented successes as well as ongoing challenges in the cancer field

Apr 1^st • 2 mins read

Carina Dolan, PharmD, BCOP

Opportunities and challenges in biosimilar uptake in oncology

Jun 26^th • 7 mins read

Yan Ji, Jin Y. Jin, David M. Hyman, Geoffrey Kim and Ajit Suri

Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology

Jul 11^th • 10 mins read